Parkinson's disease: carbidopa, nausea, and dyskinesia.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 189, doi. 10.2147/CPAA.S72234
- By:
- Publication type:
- Article
Works matching IS 11791438 AND DT 2014 AND VI 6
Results: 18
1
2
Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 195, doi. 10.2147/CPAA.S71574
- By:
- Publication type:
- Article
3
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 179, doi. 10.2147/CPAA.S61131
- By:
- Publication type:
- Article
4
The Parkinson's disease death rate: carbidopa and vitamin B6.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 161, doi. 10.2147/CPAA.S70707
- By:
- Publication type:
- Article
5
Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 171, doi. 10.2147/CPAA.S70490
- By:
- Publication type:
- Article
6
Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug-drug interaction study.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 149, doi. 10.2147/CPAA.S64131
- By:
- Publication type:
- Article
7
Reducing medication errors in critical care: a multimodal approach.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 117, doi. 10.2147/CPAA.S48530
- By:
- Publication type:
- Article
8
Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 139, doi. 10.2147/CPAA.S44377
- By:
- Publication type:
- Article
9
Melatonergic drugs in development.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 127, doi. 10.2147/CPAA.S36600
- By:
- Publication type:
- Article
10
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 107, doi. 10.2147/CPAA.S67271
- By:
- Publication type:
- Article
11
Effect of age and sex on warfarin dosing.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 103, doi. 10.2147/CPAA.S66776
- By:
- Publication type:
- Article
12
Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 111, doi. 10.2147/CPAA.S59376
- By:
- Publication type:
- Article
13
In vitro microdialysis membrane efficiency of broad-spectrum antibiotics in combination and alone.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 97, doi. 10.2147/CPAA.S65389
- By:
- Publication type:
- Article
14
Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 87, doi. 10.2147/CPAA.S62512
- By:
- Publication type:
- Article
15
Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 79, doi. 10.2147/CPAA.S61462
- By:
- Publication type:
- Article
16
Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 71, doi. 10.2147/cpaa.s57442
- By:
- Publication type:
- Article
17
Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 63
- By:
- Publication type:
- Article
18
Population pharmacokinetics of olprinone in healthy male volunteers.
- Published in:
- Clinical Pharmacology, 2014, v. 6, p. 43, doi. 10.2147/CPAA.S50626
- By:
- Publication type:
- Article